Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase-Reference-Cited by-同舟云学术

Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase

Published:2014-11-24 Issue:24 Volume:171 Page:5870-5880
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Fry J P¹,Li K Y¹,Devall A J²,Cockcroft S¹,Honour J W³⁴,Lovick T A⁵

Affiliation:

1. Department of Neuroscience, Physiology and Pharmacology; University College London (UCL); London UK

2. School of Clinical and Experimental Medicine; University of Birmingham; Birmingham UK

3. Institute of Women's Health; University College London (UCL); London UK

4. Department of Chemical Pathology; University College London Hospital; London UK

5. School of Physiology and Pharmacology; University of Bristol; Bristol UK

Funder

Medical Research Council

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12891/fullpdf

Reference58 articles.

1. The Concise Guide to PHARMACOLOGY 2013/14: Enzymes;Alexander;Br J Pharmacol,2013a

2. The Concise Guide to PHARMACOLOGY 2013/14: Transporters;Alexander;Br J Pharmacol,2013b

3. The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels;Alexander;Br J Pharmacol,2013c

4. The role of hormones and hormonal treatments in premenstrual syndrome;Backstrom;CNS Drugs,2003

5. Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease;Bauman;Mol Endocrinol,2006

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study;Psychoneuroendocrinology;2023-11

2. Drugs possessing aryloxypropanamine pharmacophore, duloxetine, dapoxetine and propranolol, increase allopregnanolone in rat brain: Possible involvement of allopregnanolone in their central nervous system effects;Steroids;2023-10

3. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder;CNS Drugs;2023-05

4. Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development;Frontiers in Psychiatry;2023-03-02

5. The novel rapid-acting neurosteroid-based antidepressant generation;Current Opinion in Endocrine and Metabolic Research;2022-06